FORM DEF 14A

Company

Eton Pharmaceuticals, Inc.

Filed

April 25, 2025

Period of Report

June 10, 2025

Accession Number

0001437749-25-013137

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →